Natural Alternatives Q2 net loss widens

Natural Alternatives International

13/02/2026 21:42

Overview

Nutritional supplements maker's Q2 fiscal 2026 revenue rose 2% yr/yr

Company reported a net loss of $2.6 mln for Q2 fiscal 2026

Outlook

Company anticipates net loss for second half and full fiscal 2026

NAI sees challenges in forecasting demand from multi-level marketing clients

Company anticipates net loss for full fiscal 2026 due to reduced customer forecasted sales along with delayed new product launches

Result Drivers

PRIVATE-LABEL SALES - Increased orders from existing and new customers drove a 2% rise in private-label contract manufacturing sales

CARNOSYN SALES - CarnoSyn beta-alanine sales rose 13% due to increased raw material orders, despite a decline in royalty and licensing revenue

FACTORY UTILIZATION - Losses attributed to underutilization of factory capacities despite improved gross margins and sales

Key Details

Metric
Beat/Miss
Actual
Consensus Estimate
Q2 Sales
$34.80 mln
Q2 Net Income
-$2.55 mln
Q2 Gross Profit
$2.49 mln
Q2 Operating Income
-$1.85 mln
Q2 Pretax Profit
-$2.33 mln


Press Release: ID:nGNX20Wvqh

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)